163 related articles for article (PubMed ID: 38221588)
1. Frailty is an independent factor for health-related quality of life in patients with head and neck cancer receiving definitive concurrent chemoradiotherapy.
Lu CH; Hung CY; Hsueh SW; Yeh KY; Hung YS; Chou WC
Support Care Cancer; 2024 Jan; 32(2):106. PubMed ID: 38221588
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of Frailty on Treatment Outcome in Nongeriatric Patients With Head and Neck Cancer and Esophageal Cancer Undergoing Curative-Intent Concurrent Chemoradiotherapy.
Chou WC; Lai CC; Hung CY; Hsueh SW; Yeh KY; Lu CH; Tsang NM; Chang PH; Ho YW; Chen SY; Lin YC; Hung YS
Cancer Control; 2022; 29():10732748211045276. PubMed ID: 34994207
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of Vulnerability Assessment in Patients with Primary Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiation Therapy.
Chou WC; Chang PH; Chen PT; Wang HM; Yeh KY; Lu CH; Hung YS; Tung-Chieh Chang J; Tsang NM; Ho YW; Chen SY; Lee SH; Hung CY; Wang LJ; Liao KC; Lin CH; Tang WR; Lin YC
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):602-611. PubMed ID: 31987971
[TBL] [Abstract][Full Text] [Related]
4. Impact of pretreatment quality of life on tolerance and survival outcome in head and neck cancer patients undergoing definitive CCRT.
Hung CY; Hsu MH; Lee SH; Hsueh SW; Lu CH; Yeh KY; Wang HM; Chang JT; Hung YS; Chou WC
J Formos Med Assoc; 2024 Feb; ():. PubMed ID: 38331637
[TBL] [Abstract][Full Text] [Related]
5. Frailty is associated with decline in health-related quality of life of patients treated for head and neck cancer.
de Vries J; Bras L; Sidorenkov G; Festen S; Steenbakkers RJHM; Langendijk JA; Witjes MJH; van der Laan BFAM; de Bock GH; Halmos GB
Oral Oncol; 2020 Dec; 111():105020. PubMed ID: 33045628
[TBL] [Abstract][Full Text] [Related]
6. Potential Utility of the Mallampati Score for Prediction of Treatment Compliance and Safety Profiles of Patients With Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiotherapy.
Su PH; Hsu CC; Hsueh SW; Hung CY; Yeh KY; Wang HM; Lu CH; Lin YC; Chang JT; Chou WC
Anticancer Res; 2022 Nov; 42(11):5609-5618. PubMed ID: 36288852
[TBL] [Abstract][Full Text] [Related]
7. Frailty assessment by two screening instruments in non-elderly patients with head and neck cancer.
Yu SM; Hsu CC; Hsueh SW; Hung CY; Lu CH; Yeh KY; Wang HM; Lin SY; Hung YS; Chou WC
Oral Oncol; 2023 Dec; 147():106621. PubMed ID: 37931492
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of the pretreatment geriatric nutritional risk index for predicting severe adverse events in patients with head and neck cancer treated with chemoradiotherapy.
Nakayama M; Ohnishi K; Adachi M; Ii R; Matsumoto S; Nakamura M; Miyamoto H; Hirose Y; Nishimura B; Tanaka S; Wada T; Tabuchi K
Auris Nasus Larynx; 2022 Apr; 49(2):279-285. PubMed ID: 34509306
[TBL] [Abstract][Full Text] [Related]
9. Association of Deficits Identified by Geriatric Assessment With Deterioration of Health-Related Quality of Life in Patients Treated for Head and Neck Cancer.
de Vries J; Bras L; Sidorenkov G; Festen S; Steenbakkers RJHM; Langendijk JA; Witjes MJH; van der Laan BFAM; de Bock GH; Halmos GB
JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1089-1099. PubMed ID: 34673914
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the MNA-SF, MUST, and NRS-2002 nutritional tools in predicting treatment incompletion of concurrent chemoradiotherapy in patients with head and neck cancer.
Hsueh SW; Lai CC; Hung CY; Lin YC; Lu CH; Yeh KY; Tsang NM; Hung YS; Chang PH; Chou WC
Support Care Cancer; 2021 Sep; 29(9):5455-5462. PubMed ID: 33704566
[TBL] [Abstract][Full Text] [Related]
11. Predictive Value of Albumin and Neutrophil-to-Lymphocyte Ratio Score for Treatment Completeness and Safety Profiles in Patients With Head and Neck Cancer Receiving Definitive Concurrent Chemoradiotherapy.
Hsu CC; Chou WC; Hung YS; Lin SY; Hung CY; Yeh KY; Wang HM; Lu CH
In Vivo; 2022; 36(6):2875-2883. PubMed ID: 36309354
[TBL] [Abstract][Full Text] [Related]
12. Effect of prophylactic tube feeding in head and neck cancer patients with high Mallampati score undergoing definitive concurrent chemoradiotherapy.
Lu CH; Hsu CC; Su PH; Lin SY; Yeh KY; Hsueh SW; Chang JT; Wang HM; Hung YS; Chou WC
Support Care Cancer; 2023 Jun; 31(7):384. PubMed ID: 37289404
[TBL] [Abstract][Full Text] [Related]
13. The Geriatric Nutritional Risk Index as a prognostic factor in older adult patients with locally advanced head and neck cancer receiving definitive chemoradiotherapy with tri-weekly cisplatin.
Fujiwara Y; Sato Y; Hayashi N; Fukuda N; Wang X; Nakano K; Ohmoto A; Urasaki T; Ono M; Tomomatsu J; Toshiyasu T; Mitani H; Takahashi S
J Geriatr Oncol; 2023 Jun; 14(5):101523. PubMed ID: 37229881
[TBL] [Abstract][Full Text] [Related]
14. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module.
Rosenthal DI; Mendoza TR; Fuller CD; Hutcheson KA; Wang XS; Hanna EY; Lu C; Garden AS; Morrison WH; Cleeland CS; Gunn GB
Cancer; 2014 Jul; 120(13):1975-84. PubMed ID: 24711162
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenia predicts a poor treatment outcome in patients with head and neck squamous cell carcinoma receiving concurrent chemoradiotherapy.
Shodo R; Yamazaki K; Ueki Y; Takahashi T; Horii A
Eur Arch Otorhinolaryngol; 2021 Jun; 278(6):2001-2009. PubMed ID: 32772234
[TBL] [Abstract][Full Text] [Related]
16. A prospective nutritional assessment using Mini Nutritional Assessment-short form among patients with head and neck cancer receiving concurrent chemoradiotherapy.
Hung CY; Hsueh SW; Lu CH; Chang PH; Chen PT; Yeh KY; Wang HM; Tsang NM; Huang PW; Hung YS; Chen SC; Chou WC
Support Care Cancer; 2021 Mar; 29(3):1509-1518. PubMed ID: 32710174
[TBL] [Abstract][Full Text] [Related]
17. Nutrition impact symptoms and associated outcomes in post-chemoradiotherapy head and neck cancer survivors: a systematic review.
Crowder SL; Douglas KG; Yanina Pepino M; Sarma KP; Arthur AE
J Cancer Surviv; 2018 Aug; 12(4):479-494. PubMed ID: 29556926
[TBL] [Abstract][Full Text] [Related]
18. Change in Physical Performance Correlates with Decline in Quality of Life and Frailty Status in Head and Neck Cancer Patients Undergoing Radiation with and without Chemotherapy.
Farrugia M; Erickson K; Wendel E; Platek ME; Ji W; Attwood K; Ma SJ; Gu F; Singh AK; Ray AD
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33915867
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal Assessment of Frailty and Quality of Life in Patients Undergoing Head and Neck Surgery.
Thomas CM; Sklar MC; Su J; Xu W; De Almeida JR; Alibhai SMH; Goldstein DP
Laryngoscope; 2021 Jul; 131(7):E2232-E2242. PubMed ID: 33427307
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and Efficacy of Inspiratory Muscle Training in Patients with Head and Neck Cancer receiving Concurrent Chemoradiotherapy.
Vira P; Samuel SR; Rai Pv S; Saxena PP; Amaravadi SK; Ravishankar N; Balachandran DD
Asian Pac J Cancer Prev; 2021 Dec; 22(12):3817-3822. PubMed ID: 34967560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
